Delivery Order SPE2DB20D3103-SPE2DB24FP2H0

Award Date 6/18/24
Potential Completion Date 7/11/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,518.40, is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the delivery of the prescription drug NUBEQA (300 mg tablet, 120 count). The contract has a firm fixed price of $7,036.80 and a completion date of July 19, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (DO) valued at $7,036.80 for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has a completion date of July 22, 2024 and was awarded on June 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract, valued at $3,518.40, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a federal agency within the Department of Defense. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $10,555.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NUBEQA 300 MG TABLET 120S. The contract is a Firm Fixed Price Delivery Order with a completion date of July 25, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide NUBEQA 300 MG TABLET 120S, a pharmaceutical product, for $10,555.20. This Firm Fixed Price contract has a completion date of June 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order contract with a Firm Fixed Price pricing type. It has a ceiling value of $3,518.40 and an ultimate completion date of July 22, 2024. The contract was awarded on June 28, 2024 by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract is for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. This award is associated...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $7,036.80, is a Delivery Order for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has a firm fixed price and an ultimate completion date of June 7, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,036.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,042,325 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. This delivery order falls under a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA to supply a comprehensive range of medications and medical supplies to support...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP2H0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products, including the prescription drug NUBEQA 300 MG TABLET 120S, to the Defense Logistics Agency (DLA). The $3,518.40 firm fixed-price delivery order has a completion date of July 11, 2024 and is not designated as a set-aside contract.

Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 9/17/24, 9:49 AM